Literature DB >> 36119299

Prevalence and predictors of thyroid dysfunction amongst patients with Type 2 diabetes mellitus in Pakistan.

Syeda Iffat Bukhari1, Gohar Ali1, Muhammad Yahya Memom1, Nabiya Sandeelo1, Haris Alvi2, Abu Talib1, Imtiaz Ahmed1, Hari Lal1, Muhammad Sohaib Asghar2, Ushna Naseer3.   

Abstract

Introduction: Diabetes and thyroid disorders are the two most common disorders amongst endocrine diseases. Uncontrolled diabetes mellitus (DM) may disturb thyroid metabolism by disturbing the levels of thyroid hormones in the plasma. This study was undertaken to determine the prevalence and thyroid dysfunction in type 2 diabetic population presenting in a public sector tertiary care teaching hospital. Materials and
Methods: This descriptive cross-sectional study was conducted in Civil Hospital Karachi (CHK) in the department of medicine from October 01, 2018, to March 31, 2019. The study population consisted of 317 patients diagnosed with DM type 2 based on American Diabetes Association (ADA) criteria. Patients with fasting blood sugar ≥ 126 mg/dL, or HbA1c >6.5 (%), and 2 h postprandial blood glucose levels >200 mg/dL were included. After a minimum of 8 h of fasting, plasma samples of patients were collected and sent for fasting blood glucose, HbA1c, FT3, FT4, and thyroid-stimulating hormone (TSH). Descriptive statistics were calculated. Post-stratification Chi-squared test was applied, and a P value of ≤ 0.05 was considered significant.
Results: Among all enrolled DM type 2 patients, 207 (65.3%) were male with a mean age of 46.54 ± 8.72 years. Mean fasting blood sugar (FBS), random blood sugar (RBS), and HbA1c were 212.76 ± 26.91 (mg/dL), 328.89 ± 52.89 (mg/dL), and 9.43 ± 2.47 (%), respectively. The mean duration of DM was 7.81 ± 3.15 years. Mean FT3, FT4, and TSH were 113.13 ± 44.40 (ng/dL), 7.63 ± 3.11 (mg/dL) and 2.64 ± 2.57 (mIU/mL), respectively. In the present study, 55 (17.4%) patients had subclinical hypothyroidism, 27 (8.5%) had hypothyroidism, 19 (6.0%) had hyperthyroidism, and 16 (5.0%) had subclinical hyperthyroidism. Significant association of thyroid dysfunction was established with age group, female gender, and family history of thyroid dysfunction (P =< 0.001).
Conclusion: The prevalence of thyroid dysfunction is higher among patients with type 2 diabetes mellitus (T2DM), in which hypothyroidism was the most common dysfunction with more prevalence among female patients. Copyright:
© 2022 Journal of Family Medicine and Primary Care.

Entities:  

Keywords:  FT3; FT4; TSH; hyperthyroidism; hypothyroidism; thyroid dysfunction; type II diabetes mellitus

Year:  2022        PMID: 36119299      PMCID: PMC9480699          DOI: 10.4103/jfmpc.jfmpc_2106_21

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

Diabetes mellitus (DM) is the most common endocrine disorder caused by the dysfunction of pancreatic b cells.[1] In 2019, it was reported that globally 463 million adults (age 20–79 years) were living with diabetes, 79% of whom were living in low- and middle-income countries.[1] According to the American Diabetes Association (ADA), additional 374 million people are at risk for developing type 2 diabetes mellitus (T2DM).[2] Thyroid dysfunction is ranked as the second most common endocrine disorder.[3] In the USA, 4.6% of the population were diagnosed with hypothyroidism, and 1.3% had hyperthyroidism, whereas these figures were 3.05% and 0.75% in Europe, respectively.[4] It has been documented that diabetic patients are more susceptible to developing thyroid dysfunction, and many clinical trials have been conducted across the globe to understand the link between them.[5] Several studies have reported the prevalence of thyroid dysfunction among patients with DM to be varying from 4% to 35%.[678] Recent studies have reported insulin resistance as a major factor in disrupting thyroid hormone functions and causing hypothyroidism in T2DM patients.[5] It does this by modifying thyroid-stimulating hormone (TSH) released from the hypothalamus or affecting peripheral tissue conversion of tetraiodothyronine (T4) to triiodothyronine (T3).[59] In subclinical hypothyroidism, the declining rate of insulin-induced glucose transport is thought to be due to the disrupted gene translocation of glucose type 2 receptor (GLUT-2), leading to insulin resistance.[10] A study conducted by Elgazar et al.[11] showed a greater incidence of thyroid dysfunction among patients with higher HbA1c levels. Thyroid dysfunction has also been associated with increased levels of serum cholesterol and triglycerides, which amplify the risk of cardiovascular disorders in diabetic patients.[1112] Although various studies have been conducted showing the link of thyroid dysfunction to DM, data from Pakistan are lacking in this regard. In this study, we aim to assess the incidence of thyroid disorders in the diabetic population with relation to age and gender in the Pakistani population, which would prompt primary care physicians to take necessary measures for public health awareness among the masses.

Methodology

Study design and location

The study design of the research was analytical cross-sectional conducted in the department of medicine, Civil Hospital Karachi (CHK), Pakistan from October 01, 2018, to March 31, 2019.

Sample size

The sample size was calculated through the OpenEpi software, the prevalence of thyroid disorders was 29%[13] among TD2M patients, the margin of error was 5%, and confidence interval of 95%, then at least n = 317 participants were required.

Patient selection

In this study, 317 diabetic patients were selected, who were attending the out-patient department (OPD), with non-probability, consecutive sampling technique, who fulfilled the selection criteria. Patients of age between 35 and 65 years of having fasting blood sugar of ≥126 mg/dL at two or more occasions, or HbA1c >6.5%, or 2 h glucose levels >200 mg/dL were enrolled in the study as per the selection criteria. All study participants were diagnosed cases of T2DM for a minimum of 2 years duration and were taking oral hypoglycemic agents, insulin, or both. Informed consent was taken from each patient for participating in the study. Patients with any history of thyroid disorders or those who had undergone any thyroid surgery were not included in the study. Those patients who were taking any medication affecting glycemic status such as steroids for any disease, for any duration, diagnosed case of type-1 DM, critically ill patients, and those taking medication affecting thyroid function were not enrolled.

Ethical approval

The research evaluation unit (REU) committee approved the research synopsis with REU No. 34,936, College of Physicians & Surgeons Pakistan (CPSP).

Data collection and statistical analysis

Information regarding age, gender, and clinical history of diabetes was documented on a pre-approved proforma. Venous samples of participants were collected after a minimum of 8 h fasting for measurement of fasting blood glucose levels, HbA1c, FT3, FT4, and TSH levels in plasma. Statistical analysis of composed data was performed via Statistical Package SPSS (version 20.0). Frequency and percentage were computed for categorical variables such as the occurrence of hyperthyroidism, hypothyroidism, subclinical hyperthyroidism, and subclinical hypothyroidism and gender. Mean and standard deviations (SD) were calculated for numeric variables such as age and duration of T2DM. Effect modifiers such as age, gender, duration of diabetes mellitus, and family history of thyroid dysfunction were controlled through stratification. Post-stratification Chi-squared test was applied among different strata to calculate any significant differences, and ≤ 0.05 was considered significant as P value.

Results

Out of the sample population of 317 T2DM patients, 207 (65.3%) were males and 110 (34.7%) were females. Overall, 37% of participants had thyroid dysfunction. The mean age was 46.54 ± 8.72 years. The mean duration of diabetes was 6.80 ± 2.62. Mean fasting blood sugar, random blood sugar, and HbA1c were 212.76 ± 26.91 (mg/dL), 328.89 ± 5.89 (mg/dL), and 9.43 ± 2.47 (%), respectively [Table 1]. The mean duration of DM was 7.81 ± 3.15 years. Mean FT3, FT4 and TSH were 113.13 ± 44.40 (mg/dL), 7.63 ± 3.11 (mg/dL), and 2.64 ± 2.57 (mIU/mL), respectively. In the sample population, 15 (4.7%) reported a family history of thyroid dysfunction, whereas 302 (95.3%) answered negatively in response to this question.
Table 1

Demographic and clinical characteristics of study participants (n=317)

CharacteristicsMean±SD/n (%)
Age (years)46.54±8.72
Gender
 Female110 (34.7)
 Male207 (65.3)
Duration of diabetes mellitus (years)6.80±2.62
FBS (mg/dL)212.76±26.91
RBS (mg/dL)328.89±52.89
Hb1Ac9.43±2.47
Total no. of people with thyroid dysfunction117 (37%)
FT3 (ng/dL)113.13±44.40
FT4 (mg/dL)7.63±3.11
TSH (µIU/mL)2.64±2.57
Family history of thyroid dysfunction
 Yes302 (95.3)
 No15 (4.7)
Demographic and clinical characteristics of study participants (n=317) In the present study, 200 (63.1%) patients had normal thyroid function, 55 (17.4%) patients had subclinical hypothyroidism, 27 (8.5%) had hypothyroidism, 19 (6.0%) had hyperthyroidism, and 16 (5.0%) had subclinical hyperthyroidism as shown in Figure 1.
Figure 1

Distribution of thyroid function among type 2 diabetic patients

Distribution of thyroid function among type 2 diabetic patients The results showed a significant association of clinical hyperthyroidism with age, 11 (57.9%) between 56 and 65 age group (P ≤ 0.001), out of the total 19 cases of clinical hyperthyroidism 13 (68.4%) were females (P ≤ 0.001). Also, a significant association of subclinical hyperthyroidism with age was found with 8 (50%) in each age group (46–55) and (56–65) years (P ≤ 0.001), out of the total 16 cases of subclinical hyperthyroidism, 11 (68.8%) were females (P ≤ 0.001) as shown in Table 2.
Table 2

Association of clinical hyperthyroidism and Subclinical hyperthyroidism according to age, gender, and thyroid dysfunction family history (n=317)

Thyroid function CharacteristicsEuthyroid n (%) (n=200)Clinical hyperthyroidism n (%) (n=19) P Subclinical hyperthyroidism n (%) (n=16) P
Age groups (years)<0.001<0.001
 35-45128 (64)5 (26.3)0 (0.0)
 46-5539 (19.5)3 (15.8)8 (50)
 56-6533 (16.5)11 (57.9)8 (50)
Gender<0.001<0.001
 Female47 (23.5)13 (68.4)11 (68.8)
 Male153 (76.5)6 (31.6)5 (31.2)
Family History of thyroid dysfunction0.005<0.001
 No198 (99)16 (84.2)12 (75)
 Yes2 (1)3 (15.8)4 (25)

P≤0.05 considered as significant

Association of clinical hyperthyroidism and Subclinical hyperthyroidism according to age, gender, and thyroid dysfunction family history (n=317) P≤0.05 considered as significant The results showed a significant association of clinical hypothyroidism with age, more common 16 (59.3%) in the age group (56–65) year (P = 0.001), out of the total 27 cases of clinical hypothyroidism, 14 (51.9%) were females (P ≤ 0.001), as shown in Table 3.
Table 3

Association of clinical hypothyroidism and subclinical hypothyroidism according to age, gender, and thyroid dysfunction family history (n=317)

Thyroid function CharacteristicsEuthyroid n (%) (n=200)Clinical hypothyroidism n (%) (n=27) P Subclinical hypothyroidism n (%) (n=55) P
Age groups (years)<0.0010.005
 35-45128 (64)0 (0.0)41 (74.5)
 46-5539 (19.5)11 (40.7)14 (24.5)
 56-6533 (16.5)16 (59.3)0 (0.0)
Gender0.0020.001
 Female47 (23.5)14 (51.9)25 (45.5)
 Male153 (76.5)13 (48.1)30 (54.5)
Family history of thyroid dysfunction0.0130.069
 No198 (99)24 (88.9)52 (94.5)
 Yes2 (1)3 (11.1)3 (5.5)

P≤0.05 considered as significant

Association of clinical hypothyroidism and subclinical hypothyroidism according to age, gender, and thyroid dysfunction family history (n=317) P≤0.05 considered as significant

Discussion

The coexistence of DM and thyroid disorders is a well-established fact. These conditions are two of the most common endocrine diseases that clinicians come across in clinical practice.[14] In this study, we have assessed the incidence of thyroid dysfunction in T2DM patients and their relation to gender and age in the Pakistani population. In our study, the overall prevalence of thyroid dysfunction in T2DM patients was slightly higher, that is, 37% compared to 29%, 31%, and 35% reported in different studies.[111315] The slightly higher rate can be attributed to the differences in ethnicity and the dietary pattern of the region.[1617] In our study, we found subclinical hypothyroidism (17.4%) to be the most common thyroid disorder associated with DM, followed by hypothyroidism (8.5%), hyperthyroidism (5.0%), and subclinical hyperthyroidism (6.0%), which is in concordance to the studies conducted in India and Bangladesh.[1819] The higher rate of subclinical disease in the diabetic population deems it necessary to screen the patients presenting with T2DM because concomitant thyroid disorder can have a major impact on the glycemic levels and the overall management of the diabetic patient.[14] According to Ogbonna et al., females with T2DM have a 3.8 times greater chance of developing thyroid dysfunction as compared to males.[22] This can be ascribed to the effect the estrogen hormone has on the thyroid follicular cells and thyroxine-binding globulin (TBG).[21] Our results are consistent with these findings as the prevalence of all four types of thyroid disorders was higher among diabetic females (P ≤ 0.001) than their male counterparts, this is also in line with the other studies conducted in the past.[112223] The incidence of clinical hypothyroidism, hyperthyroidism, and subclinical hyperthyroidism in the diabetic population was significantly associated with age as the majority of the cases were reported in the (56–65) age range (P ≤ 0.001) and follows the same trend as the study of Khassawneh et al.,[24] in which the prevalence of thyroid dysfunction in the diabetic population significantly increased with the increasing age. However, a unique finding in our study was that a higher proportion of cases of subclinical hypothyroidism were reported in the younger population, approximately 74.5% in the (35–45) age range. Hyperthyroidism increases metabolism in the body and leads to early processing and elimination of insulin from the body.[25] Hypothyroidism, on the one hand, slows down the metabolic rate and on the other hand, is associated with insulin sensitivity, both of these factors can contribute to hypoglycemia.[2627] Dose adjustment for insulin is needed when a diabetic patient concomitantly suffers from both endocrinopathies. Based on our research findings, we recommend regular screening of the diabetic population for underlying thyroid disorders, especially for older adults and females presenting with diabetes, to ensure early detection of thyroid disorder and better glycemic control to prevent complications in the long run with poorly controlled diabetes. With respect to primary care physicians, the challenges of obesity and unhealthy lifestyle practices prompt the role of primary care physicians in incorporating healthy lifestyles by promoting awareness and supporting ideas of those healthy practices in diabetes and thyroid disorders.

Study Limitations

The present study is a non-randomized, observational study and is thus limited by patient selection bias. This study was a single hospital-based study with small sample size; therefore, the results might not be generalizable to larger populations. Although family history is a confounding factor, the number of patients with a positive family history was minimal.

Conclusion

The prevalence of thyroid dysfunction is higher among patients with T2DM, in which hypothyroidism was more prevalent in females than males. Age more than 40 years, family history of diabetes and thyroid dysfunction, female gender were also significant risk factors.

Take home messages

Our study reported the frequency of thyroid disorders within the diabetic population. Certain unhealthy lifestyle changes causing sedentary habits prompt primary care physicians to have a role to play in preventing unhealthy lifestyles by promoting awareness and supporting healthy practices including physical activity and a balanced diet in these diabetic individuals with thyroid discrepancies.

Ethical approval statement

Ethical approval was taken in this study from the institutional review board of Dow University Hospital, and consent to participants was taken from all respondents.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  14 in total

Review 1.  Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies.

Authors:  R Kadiyala; R Peter; O E Okosieme
Journal:  Int J Clin Pract       Date:  2010-07       Impact factor: 2.503

2.  Thyroid dysfunction prevalence and relation to glycemic control in patients with type 2 diabetes mellitus.

Authors:  Essmat Hassan Elgazar; Noha Elsayed Esheba; Safenaz Alsaeed Shalaby; Wael Farrag Mohamed
Journal:  Diabetes Metab Syndr       Date:  2019-07-09

3.  Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT).

Authors:  T Bjoro; J Holmen; O Krüger; K Midthjell; K Hunstad; T Schreiner; L Sandnes; H Brochmann
Journal:  Eur J Endocrinol       Date:  2000-11       Impact factor: 6.664

Review 4.  The interface between thyroid and diabetes mellitus.

Authors:  Leonidas H Duntas; Jacques Orgiazzi; Georg Brabant
Journal:  Clin Endocrinol (Oxf)       Date:  2011-07       Impact factor: 3.478

5.  Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case-Control Study.

Authors:  Adi H Khassawneh; Abdel-Hameed Al-Mistarehi; Anas M Zein Alaabdin; Laith Khasawneh; Thekraiat M AlQuran; Khalid A Kheirallah; Nesreen A Saadeh; Othman Beni Yonis; Mohamid Shawkat; Nail Obeidat
Journal:  Int J Gen Med       Date:  2020-10-12

6.  The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis.

Authors:  Ane Garmendia Madariaga; Silvia Santos Palacios; Francisco Guillén-Grima; Juan C Galofré
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

7.  Thyroid Dysfunction in Type 2 Diabetes Mellitus Patients.

Authors:  Imam Subekti; Laurentius Aswin Pramono; Esthika Dewiasty; Dante Saksono Harbuwono
Journal:  Acta Med Indones       Date:  2017-10

8.  Thyroid disorders and diabetes mellitus.

Authors:  Mirella Hage; Mira S Zantout; Sami T Azar
Journal:  J Thyroid Res       Date:  2011-07-12

9.  Prevalence of thyroid dysfunction among greek type 2 diabetic patients attending an outpatient clinic.

Authors:  Athanasia Papazafiropoulou; Alexios Sotiropoulos; Anthi Kokolaki; Marina Kardara; Petroula Stamataki; Stavros Pappas
Journal:  J Clin Med Res       Date:  2010-03-25

10.  Risk Factors of Thyroid Dysfunction in Patients With Type 2 Diabetes Mellitus.

Authors:  Stanley U Ogbonna; Ignatius U Ezeani
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.